share_log

JP Morgan Maintains Neutral on Ionis Pharmaceuticals, Lowers Price Target to $47

Benzinga ·  Mar 11 14:55

JP Morgan analyst Jessica Fye maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Neutral and lowers the price target from $51 to $47.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 342

Recommended

Write a comment